Up to your NEK2 in CIN

por Seachrist, Darcie D., Anstine, Lindsey J., Keri, Ruth A.
Publicado 2021

FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer

por Seachrist, Darcie D., Anstine, Lindsey J., Keri, Ruth A.
Publicado 2021

Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer

por Seachrist, Darcie D., Sizemore, Steven T., Johnson, Emhonta, Abdul-Karim, Fadi W., Weber Bonk, Kristen L., Keri, Ruth A.
Publicado 2017

TGF-β/activin signaling promotes CDK7 inhibitor resistance in triple-negative breast cancer cells through upregulation of multidrug transporters

por Webb, Bryan M., Bryson, Benjamin L., Williams-Medina, Eduardo, Bobbitt, Jessica R., Seachrist, Darcie D., Anstine, Lindsey J., Keri, Ruth A.
Publicado 2021

KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene

por Roberts, Melyssa S., Anstine, Lindsey J., Finke, Viviane S., Bryson, Benjamin L., Webb, Bryan M., Weber-Bonk, Kristen L., Seachrist, Darcie D., Majmudar, Parth R., Keri, Ruth A.
Publicado 2020

Disruption of CDK7 signaling leads to catastrophic chromosomal instability coupled with a loss of condensin-mediated chromatin compaction

por Piemonte, Katrina M., Webb, Bryan M., Bobbitt, Jessica R., Majmudar, Parth R., Cuellar-Vite, Leslie, Bryson, Benjamin L., Latina, Nicholas C., Seachrist, Darcie D., Keri, Ruth A.
Publicado 2023